Prevention of osteoporosis in cardiac transplant recipients

Current Opinion in Cardiology

Volumn 17, Issue 2, 2002, Pages 160-164

  Pisani, Barbara ^a   Mullen, G Martin ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCIFEDIOL; CALCITONIN; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CITRATE CALCIUM; CONJUGATED ESTROGEN; ESTROGEN; ETIDRONIC ACID; GESTAGEN; PAMIDRONIC ACID; SALCATONIN; STEROID; VITAMIN D;

BONE ATROPHY; BONE DENSITY; BONE MINERAL; DRUG INDUCED DISEASE; HEART TRANSPLANTATION; HORMONE SUBSTITUTION; HUMAN; MORBIDITY; OSTEOPOROSIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; REVIEW; VERTEBRA FRACTURE;

BONE DENSITY; CALCITONIN; DIPHOSPHONATES; FEMALE; HEART TRANSPLANTATION; HORMONE REPLACEMENT THERAPY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OSTEOPOROSIS; RISK FACTORS;

EID: 0036233604     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200203000-00006     Document Type: Review

References (42)

1. Osteoporosis prevention, diagnosis, and therapy
2. Glucocorticoid-associated osteoporosis. World Congress on Osteoporosis 2000
3. Prevention of osteoporosis after cardiac transplantation: A prospective, longitudinal, randomized, double-blind trial with calcitriol
4. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)
5. Organ transplantation and osteoporosis
6. Pathogenesis and management of transplantation osteoporosis
7. Osteoporosis after organ transplantation
8. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry
9. Posttransplant bone disease: The role of immunosuppressive agents on the skeleton
10. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
11. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure
12. Osteoporosis and bone morbidity in cardiac transplant recipients
13. Bone loss and turnover after cardiac transplantation
14. Prevention of loss of vertebral bone density in heart transplant patients
15. Magnesium deficiency and bone loss after cardiac transplantation
16. Glucocorticoid-induced osteopenia in adolescent heart transplant recipients
17. Resistance exercise training restores bone mineral density in heart transplant recipients
18. Timing and quantification of bone loss in cardiac transplant recipients
19. Bone mineral loss and recovery after cardiac transplantation
20. Prevention of bone loss after heart transplantation with antiresorptive therapy: A pilot study
21. Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients
22. Osteoporosis after cardiac transplantation
23. Bone loss after heart transplantation: A prospective study
24. Frequency and predictors of osteoporosis fractures after cardiac or liver transplantation: A follow-up study
25. Osteoporosis in heart transplant recipients: A longitudinal study
26. Reduced bone mineral density in men after heart transplantation
27. Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation
28. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation
29. The role of testosterone in cyclosporine-induced osteopenia
30. Loss of vertebral bone density in heart transplant patients
31. Bone loss after cardiac transplantation: Effects of calcium, calcidiol, and monofluorophosphate
32. Bone loss and fracture after lung transplantation
33. Are bisphosphonates useful in the management of corticosteroids induced osteoporosis in transplant patients?
34. Prevention of bone loss in cardiac transplant recipients: A comparison of biphosphonates and vitamin D
35. Protective effect of short-term calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation
36. Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation
37. Prevention of osteoporosis in heart transplant recipients: A comparison on calcitriol with calcitonin and pamidronate
38. Intravenous pamidronate as treatment for osteoporosis after heart transplantation: A prospective study
39. Outcome of osteoporosis prevention with pamidronate in cardiac recipients
40. Bone mineral density in lung-transplantation recipients before and after graft: Prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate
41. Alendronate treatment to prevent osteoporotic fractures
42. Progression of steroid-associated osteoporosis after heart transplantation